Steve became CEO of Riverain Technologies in 2013 after joining Riverain as Vice President of Research in 2007. His primary focus has been developing, marketing, and commercializing Riverain’s X-ray and CT product lines. Riverain ClearRead solutions significantly improve a clinician’s ability to accurately and efficiently detect disease in thoracic (lung) CT and XR images and more successfully address the challenges of early detection of lung disease.